Interview with Sena Maria, Founder, Microdosing For Resilience
Similar Posts
Moms on Mushrooms: Inside the Psychedelic Parenting Trend
Theyβre not quite hippies, and theyβre not quite 20-year-olds on the search for existential assurance. Nope. Theyβre moms, and theyβre coming out of the psychedelic closet to share how microdosing has helped them become better parents.
Interview With David Champion
Maya Healthβs Co-Founder and CEO, David Champion, discusses the importance of data and analytics in the growing psychedelic community.
Microdosing VS. Macrodosing Magic Mushrooms feat. Julianne Keu
In todayβs interview with Julianne Keu, the famous Microdoser, discussesβ¦
![The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]](https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-43-600x338.jpeg)
The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]
Hello psychedelic investors! Todayβs episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companiesβ future.
It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
Weβll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
We are going to do this because one, itβs a good article that I wanted to share with you
And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.
P.S. I mention in the video that the article Iβm discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html
Time Stamps
0:00β β Intro
3:10 β Media Coverage on Tesla & Psychedelic Stocks
6:36 β Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
8:05 β Influence on stock valuations and stealth investors
10:57 β 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow
I hope you guys found some value in this and Iβll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββ β #MindmedStockββ #PsychedelicStocks
Interview With Joshua White
Fireside Projectβs Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.
BIG MindMed MDMA Trial, Atai to Compete with Elonβs Neuralink ? (+ Updates on CMPS, MYCO and ENBI)
Hey Psychedelic Investors! Thereβs been so much news this week that we decided to split βThis Week In Psychedelic Stocksβ in 2 parts. Part Deux: β BIG MindMed MDMA Trial, Ataiβs to Compete with Teslaβs Neuralink (+Updates on CMPS, MYCO and ENBI)β might be a lot more interesting to some of you, however, I would suggest you watch Part I entitled: βHUGE Studies Released: Psychedelics About to TAKE OVER the Stock market?β That is if you are interested in the general developments in the psychedelic industry for this week.
In this episode, thereβs lots of news for the psychedelic industry writ large. Weβll start up with three different studies that were released in the first week of April.
1. Weβll cover some MindMed News [ MMED / MMEDF recently announced a new MDMA study ]
2. Atai Life Sciencesβ Computer Brain Interface & their clinical trial to treat Schizophrenia
3. Compass Pathways (CMPS) has amazing new price targets
4. Mydecine (MYCO / MYCOF ) has progressed four new compounds towards clinical trials
5. Entheonβs (ENBI / ENTBF) new Genetic Test Kit Updates
ββ¦
βTimestamps:
0:00β β Intro
1:47 β MindMedβs (MMED / MMEDF / MMQ) Announcing New Data on Personalized MDMA Dosing
6:08 β Atai Life Sciences acquires Psyber Inc to develop Brain Computer Interface -enabled digital therapeutics targeting mental health disorder
8:00 β Ataiβs Subsidiary, Recognify Life Sciences, to Commence Phase 2 clinical study in Cognitive Impairment associated with Schizophrenia
9:07 β Roth Capital Upgrades Compass Pathways (CMPS) price targets & CMPS has scheduled a corporate update
10:32 β Mydecine ( MYCOF / MYCO ) Announces Four New Lead Drug Candidates for Pre-IND Meetings with the FDA & Health Canada to prepare for clinical trials. ( MYCO 001, MYCO 002, MYCO 003 & MYCO 004 )
13:02 β Entheon Biomedical (ENBI / ENTBF ) has now launched Halugenβs Psychedelicsβ Genetic KIT
So thatβs it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this! As our thumbnail titles states: The SHROOM BOOM is REAL! Psychedelics are taking the world by storm and psychedelic inspired companies are releasing news every single day. Weβll try to cover most of them but if thereβs a company you want us to cover more in debt, please let us know in the comments and weβll try to satisfy your demands.
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
If you want to collaborate shoot us an email at: thepsychedelicinvestor@gmail.com
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifa
ββ¦
β
https://benzinga.grsm.io/thepsychedel
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββββ β#MMEDStock #CMPS Stock
Moms on Mushrooms: Inside the Psychedelic Parenting Trend
Theyβre not quite hippies, and theyβre not quite 20-year-olds on the search for existential assurance. Nope. Theyβre moms, and theyβre coming out of the psychedelic closet to share how microdosing has helped them become better parents.
Interview With David Champion
Maya Healthβs Co-Founder and CEO, David Champion, discusses the importance of data and analytics in the growing psychedelic community.
Microdosing VS. Macrodosing Magic Mushrooms feat. Julianne Keu
In todayβs interview with Julianne Keu, the famous Microdoser, discussesβ¦
The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]
Hello psychedelic investors! Todayβs episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companiesβ future.
It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
Weβll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
We are going to do this because one, itβs a good article that I wanted to share with you
And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.
P.S. I mention in the video that the article Iβm discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html
Time Stamps
0:00β β Intro
3:10 β Media Coverage on Tesla & Psychedelic Stocks
6:36 β Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
8:05 β Influence on stock valuations and stealth investors
10:57 β 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow
I hope you guys found some value in this and Iβll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββ β #MindmedStockββ #PsychedelicStocks
Interview With Joshua White
Fireside Projectβs Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.
BIG MindMed MDMA Trial, Atai to Compete with Elonβs Neuralink ? (+ Updates on CMPS, MYCO and ENBI)
Hey Psychedelic Investors! Thereβs been so much news this week that we decided to split βThis Week In Psychedelic Stocksβ in 2 parts. Part Deux: β BIG MindMed MDMA Trial, Ataiβs to Compete with Teslaβs Neuralink (+Updates on CMPS, MYCO and ENBI)β might be a lot more interesting to some of you, however, I would suggest you watch Part I entitled: βHUGE Studies Released: Psychedelics About to TAKE OVER the Stock market?β That is if you are interested in the general developments in the psychedelic industry for this week.
In this episode, thereβs lots of news for the psychedelic industry writ large. Weβll start up with three different studies that were released in the first week of April.
1. Weβll cover some MindMed News [ MMED / MMEDF recently announced a new MDMA study ]
2. Atai Life Sciencesβ Computer Brain Interface & their clinical trial to treat Schizophrenia
3. Compass Pathways (CMPS) has amazing new price targets
4. Mydecine (MYCO / MYCOF ) has progressed four new compounds towards clinical trials
5. Entheonβs (ENBI / ENTBF) new Genetic Test Kit Updates
ββ¦
βTimestamps:
0:00β β Intro
1:47 β MindMedβs (MMED / MMEDF / MMQ) Announcing New Data on Personalized MDMA Dosing
6:08 β Atai Life Sciences acquires Psyber Inc to develop Brain Computer Interface -enabled digital therapeutics targeting mental health disorder
8:00 β Ataiβs Subsidiary, Recognify Life Sciences, to Commence Phase 2 clinical study in Cognitive Impairment associated with Schizophrenia
9:07 β Roth Capital Upgrades Compass Pathways (CMPS) price targets & CMPS has scheduled a corporate update
10:32 β Mydecine ( MYCOF / MYCO ) Announces Four New Lead Drug Candidates for Pre-IND Meetings with the FDA & Health Canada to prepare for clinical trials. ( MYCO 001, MYCO 002, MYCO 003 & MYCO 004 )
13:02 β Entheon Biomedical (ENBI / ENTBF ) has now launched Halugenβs Psychedelicsβ Genetic KIT
So thatβs it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this! As our thumbnail titles states: The SHROOM BOOM is REAL! Psychedelics are taking the world by storm and psychedelic inspired companies are releasing news every single day. Weβll try to cover most of them but if thereβs a company you want us to cover more in debt, please let us know in the comments and weβll try to satisfy your demands.
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
If you want to collaborate shoot us an email at: thepsychedelicinvestor@gmail.com
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifa
ββ¦
β
https://benzinga.grsm.io/thepsychedel
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββββ β#MMEDStock #CMPS Stock
Moms on Mushrooms: Inside the Psychedelic Parenting Trend
Theyβre not quite hippies, and theyβre not quite 20-year-olds on the search for existential assurance. Nope. Theyβre moms, and theyβre coming out of the psychedelic closet to share how microdosing has helped them become better parents.
Interview With David Champion
Maya Healthβs Co-Founder and CEO, David Champion, discusses the importance of data and analytics in the growing psychedelic community.
Microdosing VS. Macrodosing Magic Mushrooms feat. Julianne Keu
In todayβs interview with Julianne Keu, the famous Microdoser, discussesβ¦
The Mainstream Media GETS Psychedelic Stocks [Like MMEDF, CMPS, EHVVF & FTRPF]
Hello psychedelic investors! Todayβs episode will be a little different. We will discuss the recent media coverage of psychedelic stocks and its role in psychedelic inspired companiesβ future.
It appears that the mainstream media understands the potential for psychedelic stocks to disrupt the pharmaceutical Industry. Now understanding what this means, and its implications is extremely important for retail investors like you and me.
Weβll also zoom into one piece of media about MindMed (MMED/MMEDF) and Compass Pathways (CMPS), and explore how it hits the nail on the head.
We are going to do this because one, itβs a good article that I wanted to share with you
And two, it exemplifies my point that the mainstream understands the potential here, and might actually be on the right side of history.
P.S. I mention in the video that the article Iβm discussing is by Yahoo Finance. It turns out the article is from OTC stock review.
For those interested in reading the entire article: https://ca.movies.yahoo.com/264-million-reasons-psychedelic-stocks-133000885.html
Time Stamps
0:00β β Intro
3:10 β Media Coverage on Tesla & Psychedelic Stocks
6:36 β Benefits of the media covering Psychedelic Companies like (MMEDF & CMPS)
8:05 β Influence on stock valuations and stealth investors
10:57 β 264 Million Reasons Why Psychedelic Stocks Have More Room To Grow
I hope you guys found some value in this and Iβll keep you posted for more changes!
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββ β #MindmedStockββ #PsychedelicStocks
Interview With Joshua White
Fireside Projectβs Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.
BIG MindMed MDMA Trial, Atai to Compete with Elonβs Neuralink ? (+ Updates on CMPS, MYCO and ENBI)
Hey Psychedelic Investors! Thereβs been so much news this week that we decided to split βThis Week In Psychedelic Stocksβ in 2 parts. Part Deux: β BIG MindMed MDMA Trial, Ataiβs to Compete with Teslaβs Neuralink (+Updates on CMPS, MYCO and ENBI)β might be a lot more interesting to some of you, however, I would suggest you watch Part I entitled: βHUGE Studies Released: Psychedelics About to TAKE OVER the Stock market?β That is if you are interested in the general developments in the psychedelic industry for this week.
In this episode, thereβs lots of news for the psychedelic industry writ large. Weβll start up with three different studies that were released in the first week of April.
1. Weβll cover some MindMed News [ MMED / MMEDF recently announced a new MDMA study ]
2. Atai Life Sciencesβ Computer Brain Interface & their clinical trial to treat Schizophrenia
3. Compass Pathways (CMPS) has amazing new price targets
4. Mydecine (MYCO / MYCOF ) has progressed four new compounds towards clinical trials
5. Entheonβs (ENBI / ENTBF) new Genetic Test Kit Updates
ββ¦
βTimestamps:
0:00β β Intro
1:47 β MindMedβs (MMED / MMEDF / MMQ) Announcing New Data on Personalized MDMA Dosing
6:08 β Atai Life Sciences acquires Psyber Inc to develop Brain Computer Interface -enabled digital therapeutics targeting mental health disorder
8:00 β Ataiβs Subsidiary, Recognify Life Sciences, to Commence Phase 2 clinical study in Cognitive Impairment associated with Schizophrenia
9:07 β Roth Capital Upgrades Compass Pathways (CMPS) price targets & CMPS has scheduled a corporate update
10:32 β Mydecine ( MYCOF / MYCO ) Announces Four New Lead Drug Candidates for Pre-IND Meetings with the FDA & Health Canada to prepare for clinical trials. ( MYCO 001, MYCO 002, MYCO 003 & MYCO 004 )
13:02 β Entheon Biomedical (ENBI / ENTBF ) has now launched Halugenβs Psychedelicsβ Genetic KIT
So thatβs it for This Week in Psychedelic Stocks fellow psychedelic investors!
I hope you guys found some value in this! As our thumbnail titles states: The SHROOM BOOM is REAL! Psychedelics are taking the world by storm and psychedelic inspired companies are releasing news every single day. Weβll try to cover most of them but if thereβs a company you want us to cover more in debt, please let us know in the comments and weβll try to satisfy your demands.
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! π
Instagram: @psychedelicinvestor
Facebook: @thepsychedelicinvestor
If you want to collaborate shoot us an email at: thepsychedelicinvestor@gmail.com
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifa
ββ¦
β
https://benzinga.grsm.io/thepsychedel
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
#MindMedββββ β#MMEDStock #CMPS Stock